Alireza Khosravi, MD - Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Ali Eghbal - Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Mohammad Kermani-Alghoraishi, MD - Assistant professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Mohaddeseh Behjati - Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Javad Shahabi - Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
Asiye Mansouri - Assistant Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

BACKGROUND: Endovascular aortic repair (EVAR) of abdominal aortic aneurysms (AAAs) has been marked as standard practice during the past decades. We aimed to investigate the shortand long-term outcomes of EVAR in patients with AAAs in Isfahan, Iran. .METHODS: This retrospective study conducted on ۵۰ patients with AAAs who have undergone EVAR procedure consequently in four different hospitals (Chamran hospital, Asgarieh hospital, Sepahan hospital and Saadi hospital) in Isfahan, Iran, between ۲۰۱۷ to ۲۰۲۰. We followed patients for one year and recorded short-term and one-year outcome include Endoleak, Aorta-iliac expansion, and mortality in hospital records during one year and telephone follow up. Data was entered in SPSS (ver.۲۵) and analyzed with Univariate Linear Regression and Chi-Square Test.RESULTS: The mean age of participants was ۶۶.۶±۱۱.۷ years old, in which ۸۸%(n=۴۴) of them were male. Elective EVAR was performed in ۸۸% of patients. Regarding the complications one year after EVAR, endoleak and CIN (contrast-induced nephropathy) were occurred in ۶%(n=۳) and ۶%(n=۳) of patients, respectively. We also reported the rate of in-hospital mortality and one-year mortality as ۲%(n=۱) and ۸%(n=۴), respectively. Univariate regression analysis revealed no significant difference regarding one-year mortality in patients who underwent EVAR. In patients who underwent spinal anesthesia in comparison with general and regional anesthesia before EVAR, there were lower rate of vascular complications [۰% (n=۰) versus ۲۳.۵% (n=۴) and ۲۰.۰% (n=۲), P=۰.۰۵۳], level of blood urea nitrogen (BUN) [۹.۸ ± ۱۳.۹ versus ۱۷.۰ ± ۱۳.۱ and ۱۴ ± ۶.۲, P=۰.۰۳۱] and creatinine (Cr) [۰.۶±۱.۱ versus ۱.۱±۰.۶ and ۱.۳±۰.۵, P=۰.۰۰۵], respectively.CONCLUSION: Desirable short- and long-term outcomes as expected, combined with a reduction in hospital length of stay and mortality and one-year mortality allowed EVAR to become the favorable therapeutic strategy for AAAs in Iran especially in high-risk patients. Lower rate of vascular complications, ICU length of stay and lower level of BUN and Cr were observed using spinal anesthesia in patients who underwent EVAR in our centers.

Abdominal aortic aneurysm, Endovascular aortic repair, Treatment Outcome